menu
    • menu

    Company profile for Salarius Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the epigenetic causes of cancers and is developing treatments for patients that need them the most. The company’s lead candidate, Seclidemstat, is currently in clinical development for treating Ewing sarcoma, for which it has Orphan Drug designation and Pediatric Rare Disease Designation by the U.S. Food and Drug Administration. Salarius believe...
    Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the epigenetic causes of cancers and is developing treatments for patients that need them the most. The company’s lead candidate, Seclidemstat, is currently in clinical development for treating Ewing sarcoma, for which it has Orphan Drug designation and Pediatric Rare Disease Designation by the U.S. Food and Drug Administration. Salarius believes that Seclidemstat could have potential for improved safety and efficacy compared to other LSD1-targeted therapies in clinical development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Salarius PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2450 Holcombe Blvd. Suite J-608 Houston TX 77021
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://salariuspharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/salarius-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SalariusPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Salarius Pharma Adjourns Meeting, Shares Reconvening Details
    Salarius Pharma Adjourns Meeting, Shares Reconvening Details

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208629/0/en/Salarius-Pharmaceuticals-Announces-Adjournment-of-Annual-Meeting-Information-for-Reconvened-Annual-Meeting.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Salarius Pharma Partners Texas Biomed For Avian Flu Research
    Salarius Pharma Partners Texas Biomed For Avian Flu Research

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196958/0/en/Salarius-Pharmaceuticals-to-Collaborate-with-Texas-Biomedical-Research-Institute-on-Avian-Flu-Study.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Salarius Pharma Notes S&P Capiq Errors Post Decoy Therapeutics
    Salarius Pharma Notes S&P Capiq Errors Post Decoy Therapeutics

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191374/0/en/Salarius-Pharmaceuticals-Cites-Errors-on-S-P-CapIQ-Platform-Following-Merger-with-Decoy-Therapeutics-Affirms-Its-Shares-Continue-to-Trade-on-the-Nasdaq-Stock-Market-Under-the-Symbo.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Salarius Pharmaceuticals And Decoy Therapeutics Complete Merger
    Salarius Pharmaceuticals And Decoy Therapeutics Complete Merger

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187388/0/en/Salarius-Pharmaceuticals-and-Decoy-Therapeutics-Complete-Merger.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Salarius Pharma Prices $7M Public Offering
    Salarius Pharma Prices $7M Public Offering

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/salarius-pharmaceuticals-announces-pricing-of-7-million-underwritten-public-offering-302611659.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    Salarius Pharma Complies With All Nasdaq Listing Rules
    Salarius Pharma Complies With All Nasdaq Listing Rules

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165547/0/en/Salarius-Pharmaceuticals-Regains-Compliance-with-All-Nasdaq-Listing-Requirements.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search